![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, May 19, 2012 4:27:59 PM
From EMEA guidelines:
"4.2.1 Primary endpoints
Weight loss is the primary endpoint. Demonstration of a clinically significant degree of weight loss of
at least 10% of baseline weight, which is also at least 5% greater than that associated with placebo, is
considered to be a valid primary efficacy criterion in clinical trials evaluating new anti-obesity drugs.
Proportions of responders in the various treatment arms could be considered as an alternative primary
efficacy criterion where response is more than 10% weight loss at the end of a 12-month period."
From the Meta Analysis of BLOOM, BLOSSOM, & BLOOM-DM:
"At one year, using Modified Intent-to-Treat with Last Observation Carried Forward analysis (MITT-LOCF) of the integrated results...22.0% of lorcaserin 10 mg BID patients and 17.3% of lorcaserin 10 mg QD patients achieved at least 10% weight loss, compared to 8.3% of patients on placebo."
So, both Lorc QD and BID 10% weight loss are > 5% difference from Placebo (BID: 22.0% - 8.3% = 13.7% QD: 17.3% - 8.3% = 9.0%). I don't see any mention of the % of patients that need to achieve 10% weight loss. All it says is "clinically significant degree of weight loss". Not sure why this is an issue...seems like Lorc clearly meets the EMEA guidelines.
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM